Heavy ion cancer therapy has attracted considerable attention in Korea because it can concentrate a powerful radiation dose inside a tumor while reducing unnecessary exposure to some surrounding tissues.

Table of Contents

It is sometimes described in Korean media as a “dream cancer treatment.” However, that expression can create the false impression that heavy ion therapy cures every cancer or automatically produces better results than surgery, chemotherapy, proton therapy, or modern X-ray radiation.

The reality is more careful.

Heavy ion therapy is a specialized form of local radiation treatment. It may be useful for selected tumors that are difficult to remove surgically, resistant to ordinary radiation, or located close to sensitive organs. It is not a universal replacement for established cancer treatment.

For foreigners considering treatment in Korea, the main points are:

Yonsei Cancer Hospital in Seoul is currently Korea’s only operating carbon-ion treatment center.
As of July 2026, Yonsei is operating one fixed-beam room and two rotating-gantry rooms.
The hospital’s publicly listed consultation categories currently include prostate, pancreatic, liver, and lung cancers.
Treatment generally involves 4 to 12 irradiation sessions, depending on the cancer and treatment plan.
The treatment itself is currently non-covered under Korean National Health Insurance.
Reported total treatment costs are commonly in the range of approximately KRW 50 million to KRW 80 million.
Korean private medical insurance may reimburse only a small portion, especially when treatment is classified as outpatient care.

Quick Answer: Where Is Heavy Ion Therapy Available in Korea?

Hospital or center	Location	Status as of July 2026	Main point
Yonsei Cancer Hospital Heavy Ion Therapy Center	Seodaemun-gu, Seoul	Operating	Korea’s only active carbon-ion treatment center
Seoul National University Hospital Gijang Heavy Ion Therapy Center	Gijang, Busan	Under construction and testing	Opening targeted for the second half of 2027
Asan Medical Center Heavy Ion Therapy Center	Songpa-gu, Seoul	Construction started	Operations targeted for 2031

Yonsei began fixed-beam carbon-ion treatment in April 2023 and added its first rotating-gantry treatment room in May 2024. In July 2026, the hospital began operating all three of its treatment rooms: one fixed-beam room and two rotating-gantry rooms.

Seoul National University Hospital is developing a heavy ion treatment center in Gijang, Busan. Its official schedule targets opening in the second half of 2027, after construction, equipment installation, testing, and regulatory preparation.

Asan Medical Center began construction of its heavy ion center in June 2026. The planned facility will include two rotating treatment systems and one fixed-beam system, with operations targeted for 2031.

Important: A hospital that has announced a heavy ion project is not necessarily accepting patients. As of July 25, 2026, foreign patients seeking treatment in Korea should contact Yonsei Cancer Hospital rather than assuming that the Busan or Asan facilities are already available.

What Is Heavy Ion Therapy?

Heavy ion therapy is a form of external-beam radiation therapy.

Conventional radiation treatment usually uses high-energy X-rays, also called photons. Heavy ion therapy instead accelerates relatively heavy atomic particles and directs them toward a tumor.

The system currently used clinically in Korea uses carbon ions. For this reason, the following expressions are commonly used to describe the same treatment:

Heavy ion therapy
Carbon ion therapy
Carbon-ion radiotherapy
Carbon-ion radiation therapy, or CIRT

Carbon ions are heavier than the hydrogen nuclei used in proton therapy. Their physical and biological characteristics allow doctors to deliver a concentrated dose to a planned depth while causing dense damage to cancer-cell DNA.

Understanding the Bragg Peak

X-rays begin releasing radiation as soon as they enter the body. They continue depositing energy before reaching the tumor and after passing through it.

Particle beams behave differently.

A carbon-ion beam releases a relatively limited amount of energy while entering the body. It then releases most of its energy at a planned depth before the radiation dose rapidly decreases. This concentration point is called the Bragg peak.

A simple way to understand it is to imagine a delivery vehicle programmed to unload most of its cargo at one specific location.

Doctors adjust the beam energy so that the high-dose region matches the tumor. Several overlapping Bragg peaks may be combined to cover the complete shape and depth of the cancer.

This does not mean that healthy tissue receives absolutely no radiation. It means that the treatment team may be able to reduce unnecessary entrance and exit radiation compared with some conventional techniques.

Carbon-Ion Therapy Versus Other Cancer Treatments

Treatment	What it uses	Main role
Conventional radiation	X-rays or photons	Widely available local treatment with extensive clinical evidence
Proton therapy	Hydrogen nuclei	Precise dose distribution using the Bragg peak
Carbon-ion therapy	Carbon nuclei	Bragg peak combined with a stronger biological effect
Surgery	Physical removal of a tumor	Preferred for many removable localized tumors
Chemotherapy	Anticancer medication	Treats cancer cells throughout the body
Targeted therapy	Medication aimed at specific cancer pathways	Used when a tumor has a relevant molecular target
Immunotherapy	Medication that activates immune responses	Used for selected cancer types and biomarkers

Carbon-ion therapy may create approximately two to three times the relative biological effect of conventional X-ray radiation in some treatment settings. However, this refers to the radiation’s cell-killing effect—not a guarantee that a patient’s survival rate will be two or three times higher.

The strongest machine is not automatically the best treatment.

The clinically important question is:

Does carbon-ion therapy provide a meaningful advantage for this particular tumor compared with the safest established alternative?

For example, a 2026 Severance Hospital specialist review noted that, for many prostate cancer patients, cure rates and major side-effect rates may not differ substantially from those achieved with other modern radiation treatments. In those cases, cost, access, convenience, and patient preference may become important parts of the decision.

Which Cancers Are Currently Evaluated in Korea?

Yonsei Cancer Hospital’s current public information lists consultations for:

Prostate cancer
Pancreatic cancer
Liver cancer
Lung cancer

Other tumor types may be discussed through specialist or multidisciplinary review, but patients should not assume that every localized cancer is currently accepted. The hospital states that additional cancer categories will be announced separately.

Treatment Candidates Versus Generally Unsuitable Cases

Category	More likely to be evaluated	Generally unsuitable as the main treatment
Disease pattern	A clearly defined localized tumor	Cancer widely spread across multiple organs
Current published cancer categories	Prostate, pancreatic, liver, and lung cancer	Leukemia and most systemic blood cancers
Treatment objective	Precise local control of a tumor	Controlling cancer cells circulating throughout the body
Typical approach	Outpatient radiation over several sessions	Systemic medication such as chemotherapy, targeted therapy, or immunotherapy
Previous treatment	Some recurrent or previously treated tumors may be reviewed	Cases where another radiation course would exceed safe organ limits
Patient condition	Able to remain in the required treatment position	Unable to tolerate immobilization or necessary preparation

This table is only a general guide. It is not a substitute for individual eligibility review.

A patient with limited metastatic disease may occasionally receive local radiation as part of a wider treatment strategy. Similarly, previous radiation therapy does not automatically exclude a patient. These cases require detailed review of earlier radiation fields, doses, organ exposure, and the location of the new tumor.

Prostate Cancer

The fixed-beam treatment room was first used for prostate cancer.

Because the prostate is relatively stable and can often be approached from fixed horizontal beam directions, it is technically suitable for fixed-beam treatment.

A typical prostate cancer plan may involve approximately 12 outpatient sessions completed within about three weeks.

However, carbon-ion therapy is only one of several options. Depending on cancer risk, age, general health, and personal priorities, alternatives may include:

Robotic or open surgery
Intensity-modulated radiation therapy
Stereotactic body radiation therapy
Brachytherapy
Active surveillance for selected low-risk cancers
Hormone therapy combined with radiation

Patients should ask whether carbon-ion therapy is expected to improve tumor control, reduce a specific side effect, shorten treatment, or mainly provide another technically advanced option.

Pancreatic Cancer

Potential candidates may include:

Patients with unresectable locally advanced pancreatic cancer
Patients who cannot undergo surgery because of age or another serious medical condition
Selected patients receiving combined chemotherapy and local radiation

Carbon-ion therapy does not automatically replace chemotherapy.

Pancreatic cancer often requires systemic treatment because cancer cells may spread beyond the visible primary tumor. Even when the carbon-ion beam successfully controls the pancreatic mass, chemotherapy may still be needed to address microscopic or distant disease.

Liver Cancer

Possible candidates may include patients with early or locally advanced liver cancer when surgery, ablation, embolization, or another treatment is difficult or could significantly reduce remaining liver function.

Eligibility depends on more than tumor size. Doctors may also evaluate:

Number of tumors
Location near major blood vessels or bile ducts
Remaining healthy liver volume
Cirrhosis
Child-Pugh liver function
Previous surgery or radiation
Evidence of disease outside the liver

Protecting the remaining liver is particularly important because many liver cancer patients already have chronic liver disease.

Lung Cancer

Yonsei’s published priority criteria have included patients with:

A single lung nodule measuring 5 centimeters or less
Stage I to IIA disease at diagnosis or recurrence
Severely reduced lung function that makes surgery difficult

These are not automatic acceptance rules. A radiation oncologist must still evaluate tumor motion, location, lymph-node involvement, previous treatments, and the radiation exposure expected in the remaining lung.

Can Recurrent Cancer Be Treated?

Possibly.

A recurrent tumor may be considered when it remains sufficiently localized and a safe treatment plan can be created.

The team may review:

The original cancer type
The site and size of the recurrence
Previous surgery
Previous radiation treatment
The dose already received by nearby organs
The time since the earlier treatment
Whether the cancer has spread elsewhere
Current organ function and general health

Re-irradiation is technically complex. The precision of a carbon-ion beam does not remove the biological limits of normal tissue that has already received radiation.

Who Is Usually Not a Good Candidate?

Heavy ion therapy is usually not the main solution for cancer that is widely distributed throughout the body.

It is generally unsuitable as the primary treatment for:

Widely metastatic cancer involving multiple organs
Leukemia
Most systemic blood cancers
Tumors that cannot be clearly defined on imaging
Patients whose condition prevents safe positioning
Cases where nearby organs cannot remain within safe radiation limits
Patients for whom surgery or another established treatment offers a clearer benefit

Yonsei explains that metastatic and blood cancers commonly require systemic treatment because cancer cells are not confined to one local target.

How Does Heavy Ion Treatment Work?

Heavy ion therapy is usually delivered as outpatient care, but the complete process includes several stages.

Step 1: Specialist Consultation

A patient normally starts with the medical department responsible for the cancer, such as:

Urology
Medical oncology
Gastroenterology
Hepatology
Pulmonology
Thoracic surgery
General surgery
Radiation oncology

The case may then be discussed through multidisciplinary review.

Step 2: Eligibility Evaluation

The hospital may request or repeat:

Pathology reports
Pathology slides or tissue blocks
CT scans
MRI scans
PET scans
Blood tests
Tumor-marker tests
Surgery records
Chemotherapy records
Previous radiation plans
Lung, liver, kidney, or heart function tests

Having one of the listed cancers does not guarantee approval.

Step 3: Immobilization and Simulation

A personalized device may be made to keep the patient in the same position during every treatment.

The patient then undergoes a planning CT scan while wearing or lying inside the immobilization device.

For tumors in the lungs, liver, or pancreas, the team may also study respiratory movement. The tumor can move as the patient breathes, so motion must be included in the treatment plan.

Step 4: Computerized Treatment Planning

Radiation oncologists and medical physicists calculate:

Beam directions
Beam energy
Target depth
Dose per session
Total treatment dose
Safety margins
Expected exposure to nearby organs
How breathing or internal movement affects the target

This planning stage is essential because carbon-ion therapy is highly sensitive to the beam’s path and stopping depth.

Step 5: Treatment Sessions

Yonsei states that its current cancer-specific treatment plans generally involve 4 to 12 irradiation sessions.

A full appointment may take approximately 10 to 40 minutes, although the beam itself may be active for only a small portion of that time. Most of the appointment is spent confirming the patient’s position and the tumor’s location.

Step 6: Follow-Up

After treatment, follow-up may include:

Blood tests
Tumor-marker testing
CT or MRI scans
PET scans when necessary
Monitoring of symptoms and organ function
Evaluation of delayed radiation effects

The tumor may not immediately disappear after radiation. Doctors usually assess response over weeks or months.

Is Heavy Ion Therapy Painful?

The radiation beam itself is not normally felt.

The patient lies still while the machine delivers the planned radiation. There is no incision, and the carbon ions do not remain inside the body.

However, some patients may find the immobilization device or treatment position uncomfortable. This can be more difficult for people with:

Severe pain
Breathing problems
Claustrophobia
Limited joint movement
Difficulty lying flat

Patients should tell the treatment team about these issues before simulation.

Possible Side Effects

Heavy ion therapy can reduce radiation exposure to some surrounding tissues, but it is not free of side effects.

Possible short-term effects may include:

Mild skin redness
Fatigue
Reduced appetite
Abdominal discomfort
Bloating
Abdominal pain
Diarrhea
Urinary or bowel irritation, depending on the treatment area

Yonsei specifically notes that upper-abdominal treatment involving areas such as the liver or pancreas may cause appetite loss, bloating, abdominal pain, or diarrhea.

Side effects can be divided into:

Acute effects: occurring during treatment or within several weeks
Late effects: appearing months or years later

The exact risks depend on the tumor location, radiation dose, organ function, previous treatment, and individual anatomy.

Patients should ask for organ-specific risks rather than relying on a general statement that heavy ion therapy has “almost no side effects.”

How Much Does Heavy Ion Therapy Cost in Korea?

There is no single universal price for every patient.

Yonsei states that the final treatment fee is calculated after the treatment plan determines the required number of sessions and technical complexity. The hospital directs patients to its non-covered medical fee information for current charges.

Published estimates commonly place a complete course at approximately:

Around KRW 50 million for some fixed-beam prostate cancer plans
Approximately KRW 60 million or more for many current treatment courses
Up to approximately KRW 80 million for some complex thoracic or abdominal cancers

Recent Korean reporting has described prostate treatment at around KRW 50 million and other complex cancer treatments averaging closer to KRW 80 million, while July 2026 reporting described current costs as at least KRW 60 million.

These figures are approximate. They are not guaranteed quotations.

Expenses That May Be Separate

A written estimate should clarify whether it includes:

Initial specialist consultation
Pathology review
CT, MRI, and PET imaging
Immobilization equipment
Simulation
Radiation treatment planning
All planned treatment sessions
Repeat planning if the tumor or body shape changes
Hospitalization
Chemotherapy
Procedures before radiation
Medications
Follow-up examinations
Interpretation
International-patient coordination
Medical documents
Accommodation and local transportation

Foreign patients should ask whether the estimate is based on Korean resident billing or international self-pay billing.

Does Korean National Health Insurance Cover It?

As of July 2026, the carbon-ion treatment fee itself is not covered by Korean National Health Insurance.

It is treated as non-covered medical care, called bigeubyeo in Korean. The patient is therefore responsible for the full heavy ion treatment charge.

Other services connected to the patient’s care may be billed separately. Depending on the service and the patient’s eligibility, some consultations, tests, medications, hospital care, or complication treatment may be covered under their own insurance rules.

Patients should not assume that Korea’s cancer copayment reduction program will reduce the carbon-ion treatment fee itself.

Korea’s annual out-of-pocket maximum also generally excludes non-covered services, so the heavy ion fee may remain outside the ordinary National Health Insurance spending cap.

Can Korean Private Medical Insurance Cover It?

Possibly—but patients should not assume that private insurance will pay most of the bill.

Korean private health coverage generally falls into two categories:

Indemnity medical insurance
Fixed-benefit cancer insurance

Indemnity Medical Insurance, or Silson Insurance

Korean indemnity medical insurance is usually called:

Silson insurance
Silbi insurance
Indemnity medical insurance

It reimburses eligible medical expenses actually paid by the patient, subject to deductibles, exclusions, policy definitions, and payment limits.

The main problem for heavy ion therapy is that treatment is commonly delivered through multiple outpatient visits.

Why Outpatient Classification Matters

For fourth-generation Korean indemnity insurance, the current non-covered outpatient limit is generally KRW 200,000 per visit, subject to the contract’s deductible and other conditions.

Fifth-generation indemnity insurance began sales in May 2026. Its severe non-covered treatment rider also generally uses a KRW 200,000 outpatient limit, although reimbursement still depends on whether the treatment meets the policy’s definition of eligible severe non-covered care.

Consider a simplified example:

Hospital bill for one carbon-ion visit: several million won
Policy outpatient limit: KRW 200,000
Number of treatment visits: 12

Even before deductibles or exclusions, the maximum reimbursement from the outpatient limit may be far below the total bill.

Older first-, second-, or third-generation policies may have different terms. Some may be more favorable, while others may contain their own outpatient limits, annual limits, or exclusions.

The policy generation alone does not determine the result. The insurer may also examine:

Medical necessity
Whether the procedure is classified as treatment or experimental care
Inpatient versus outpatient status
The billing and procedure codes
Annual non-covered limits
Deductibles and coinsurance
Previous claims
Required preauthorization
Exclusions written into the contract

Fixed-Benefit Cancer Insurance

Fixed-benefit insurance pays an agreed amount when a covered event occurs.

Possible benefits may include:

Cancer diagnosis benefit
Major cancer benefit
Radiation treatment benefit
Advanced radiation treatment benefit
Proton or heavy ion therapy rider

A general cancer diagnosis payment can usually be used toward any expense, including heavy ion therapy. However, it does not reimburse the treatment bill itself.

A specific heavy ion benefit is payable only when:

The contract includes the benefit
The diagnosis meets the policy definition
The procedure meets the rider’s definition
Waiting periods and exclusions do not apply
Required medical documents are submitted

Patients should check both their indemnity policy and any fixed-benefit cancer riders.

Questions to Ask the Insurance Company

Ask the insurer to answer the following questions in writing:

Is carbon-ion radiotherapy covered under my contract?
Which policy clause applies?
Is it treated as inpatient or outpatient care?
What is the maximum reimbursement per visit?
What is the annual maximum?
Does my policy include a heavy ion or advanced radiation rider?
Is advance authorization required?
Are treatment planning and simulation included?
Are non-covered CT, MRI, or PET scans included?
Which diagnosis and procedure codes are required?
Does the insurer require a second medical opinion?
Could the treatment affect future premiums or renewal terms?

For a bill of tens of millions of won, a telephone agent’s verbal answer is not enough. Request a written coverage interpretation or preauthorization decision whenever possible.

What About International Health Insurance?

International policies vary widely.

Some plans may cover cancer treatment in Korea, while others restrict:

Treatment outside the policyholder’s country of residence
Care outside a designated provider network
High-cost particle therapy
Treatments considered experimental for a specific cancer
Treatment started without preauthorization
Travel and accommodation expenses
Translation and medical coordination fees

Before traveling, send the insurer:

Diagnosis summary
Pathology report
Proposed treatment plan
Physician recommendation
Hospital cost estimate
Expected treatment dates
Hospital registration details

Do not rely on a general statement that the policy “covers cancer treatment.”

Contacting Yonsei as a Foreign Patient

Foreign patients should contact the Severance Hospital International Health Care Center, rather than using only the domestic reservation number.

International Health Care Center

International telephone: +82-2-2228-5800 or +82-2-2228-5810
Email: ihcc@yuhs.ac
Visa assistance telephone: +82-2-2228-5827
Location: Third floor, Severance Hospital
Address: 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea

These contact details are published by Severance Hospital’s official English-language patient service.

Patients already living in Korea may also use the general first-visit reservation center at 02-2228-8000, but overseas patients will generally receive more relevant support through the International Health Care Center.

Medical Visas for Cancer Treatment in Korea

The necessary entry status depends on nationality, treatment duration, invitation status, and immigration rules at the time of travel.

Two visa categories commonly associated with foreign medical patients are:

C-3-3 Medical Tourist Visa

The C-3-3 visa is generally intended for invited foreign patients entering Korea for medical treatment or recuperation.

The usual period of stay is up to 90 days. The inviting organization is normally a registered hospital or an authorized international-patient facilitator.

G-1-10 Treatment and Recuperation Visa

The G-1-10 category is used for longer treatment or recuperation stays and may permit a stay of up to one year, depending on approval and the individual case.

Official Korean guidance identifies both C-3-3 and G-1-10 as visa categories available to foreign patients and accompanying caregivers in qualifying cases.

Not every foreign patient needs a medical visa. Some nationalities may enter under a visa-waiver program, K-ETA, or another valid residence status.

Before booking flights, ask:

Whether the hospital can issue an appointment confirmation
Whether an invitation or sponsorship document is available
How long the complete evaluation and treatment process may take
Whether a caregiver can apply under the same medical purpose
Whether the current visa can be extended
Whether follow-up visits require remaining in Korea

The Severance International Health Care Center has a dedicated visa assistance line and can explain which hospital documents it is able to provide. Immigration eligibility itself is determined by Korean immigration authorities, not by the hospital.

Documents Foreign Patients Should Prepare

Prepare original medical documents and, where possible, English or Korean translations.

Recommended records include:

Passport
Korean residence card, if applicable
Health insurance information
Pathology report
Pathology slides or tissue blocks, if requested
CT, MRI, and PET images in DICOM format
Written radiology reports
Cancer stage and diagnosis summary
Surgery records
Chemotherapy records
Previous radiation treatment plan
Previous dose-distribution information
Current medication list
Blood-test results
Physician referral letter
Private insurance policy
Insurance preauthorization documents

Previous radiation records are particularly important. A simple statement that the patient “received radiation before” is usually not enough. The new team may need the exact treatment area, total dose, dose per session, and exposure to nearby organs.

Practical Process for a Foreign Patient

1. Collect Complete Records

Ask the current hospital for digital imaging files and detailed treatment summaries.

2. Contact the International Health Care Center

Explain:

Cancer type
Stage
Current location
Previous treatment
Whether the patient can travel
Preferred consultation timing

3. Ask About Remote Record Review

Some cases may be reviewed before the patient travels, although a final treatment decision may still require an in-person consultation and new imaging.

4. Request Separate Medical and Financial Answers

Ask for:

Whether the cancer may be considered
Which department should review the case
Required tests
Expected number of treatment sessions
Estimated waiting period
Estimated total cost
Payment schedule
Likely duration of stay in Korea
Whether a caregiver is recommended

5. Obtain Written Insurance Confirmation

Send the proposed procedure name and hospital estimate to the insurer before treatment.

6. Confirm Visa and Travel Requirements

Do not book non-refundable travel until the consultation process and immigration requirements are reasonably clear.

7. Allow Time for Planning

Four treatment sessions do not necessarily mean that the patient needs to remain in Korea for only four days.

Additional time may be needed for:

Initial consultation
Repeat pathology review
Imaging
Immobilization
Simulation
Treatment planning
Treatment sessions
Short-term follow-up

Is Heavy Ion Therapy Worth the Cost?

This decision cannot be made from the machine’s technical specifications alone.

Ask the treatment team to compare carbon-ion therapy with:

Surgery
Intensity-modulated radiation therapy
Stereotactic body radiation therapy
Proton therapy
Brachytherapy
Chemotherapy
Targeted therapy
Immunotherapy
Combined treatment

Useful questions include:

What specific advantage is expected in my case?
Is the goal cure, local control, symptom relief, or delaying progression?
Is there evidence for my exact cancer type and stage?
Would surgery provide a better chance of cure?
Is proton or modern X-ray treatment likely to provide similar results?
Which organ or side effect is the carbon-ion plan designed to protect?
What happens if the treatment does not control the tumor?
Will chemotherapy still be required?
How much of the cost is likely to remain uninsured?
Would waiting for carbon-ion treatment delay a more urgent standard treatment?

Heavy ion therapy may be a valuable option for certain difficult localized tumors. For other patients, an established treatment may offer similar results with stronger evidence, faster access, or much lower personal cost.

The right treatment is not always the newest one. It is the treatment that best matches the cancer’s biology, stage, location, and the patient’s overall condition.

Frequently Asked Questions

Is heavy ion therapy available in Korea?

Yes. As of July 25, 2026, Yonsei Cancer Hospital in Seoul is operating Korea’s only active carbon-ion treatment center. All three of its treatment rooms are now in operation.

Which hospitals will offer heavy ion therapy in the future?

Seoul National University Hospital is targeting the second half of 2027 for its Gijang center in Busan. Asan Medical Center is targeting 2031 for its center in Seoul.

Which cancers are currently listed for treatment consultation?

Yonsei currently lists prostate, pancreatic, liver, and lung cancers. Final eligibility depends on stage, location, prior treatment, organ function, and general health.

Can stage 4 cancer be treated with heavy ions?

Heavy ion therapy is a local treatment and is generally not the main treatment for widely metastatic stage 4 cancer. Selected localized lesions may occasionally be treated as part of a broader strategy, but systemic treatment is usually still required.

Can heavy ion therapy replace chemotherapy?

Not automatically. Some cancers require chemotherapy before, during, or after radiation. Pancreatic cancer, for example, commonly requires systemic treatment even when local carbon-ion therapy is considered.

How many sessions are required?

Yonsei currently states that treatment generally involves 4 to 12 irradiation sessions, depending on the cancer and treatment plan.

How long does one appointment take?

A session may take approximately 10 to 40 minutes. Most of the time is used for positioning and imaging rather than beam delivery.

Does treatment require hospitalization?

It is commonly delivered as outpatient care. Hospitalization may still be required because of another procedure, chemotherapy, complications, or the patient’s general condition.

Is heavy ion therapy painful?

The radiation beam itself is not normally felt. Remaining still in the treatment position may be uncomfortable for some patients.

How much does it cost?

A commonly reported range is approximately KRW 50 million to KRW 80 million. The actual amount depends on the cancer, number of sessions, treatment complexity, tests, and other medical services.

Does Korean National Health Insurance cover it?

No. As of July 2026, the carbon-ion treatment fee itself is non-covered and must generally be paid by the patient.

Will Korean indemnity insurance pay for it?

Possibly, but reimbursement may be limited. Fourth- and fifth-generation policies generally have a KRW 200,000 outpatient limit for the relevant non-covered outpatient benefits, which may cover only a small part of a multi-million-won treatment visit.

Can fixed-benefit cancer insurance help?

Yes, when the patient has a cancer diagnosis benefit, radiation benefit, or specific heavy ion rider that meets the policy conditions. The insurer pays the amount stated in the contract rather than automatically reimbursing the hospital bill.

Can foreigners receive treatment?

Yes, foreign patients may request consultation. They must pass the same medical eligibility review and should confirm record submission, interpretation, cost, visa, and insurance procedures before traveling.

Which medical visa may be used?

C-3-3 is commonly used for invited short-term medical patients, generally for stays of up to 90 days. G-1-10 may be used for longer treatment or recuperation, subject to immigration approval.

Is carbon-ion therapy always better than proton therapy?

No. Carbon ions have a stronger biological effect, but the best option depends on the cancer type, stage, anatomy, evidence, side-effect priorities, availability, and cost.

Disclaimer

This article provides general information about heavy ion cancer therapy in Korea as of July 25, 2026.

Hospital operations, eligible cancer types, treatment protocols, prices, waiting periods, immigration procedures, and insurance rules may change. A hospital announcement or published eligibility category does not guarantee that an individual patient will be accepted for treatment.

This article is not a diagnosis, medical recommendation, insurance interpretation, visa decision, or guarantee of treatment results. Cancer treatment decisions must be made with qualified oncology specialists after reviewing pathology, imaging, cancer stage, previous treatment, organ function, general health, and the patient’s personal priorities.

Patients should obtain current written information directly from the hospital, insurer, Korean embassy or consulate, and immigration authorities before making medical, financial, or travel decisions.